FIBROGEN INC Business Operations Contracts & Agreements

27 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 4 to Master Supply Agreement by and among FibroGen, Inc., Shanghai SynTheAll Pharmaceutical Co., Ltd., and STA Pharmaceutical Hong Kong Limited, dated as of October...
Supply Agreements
FIBROGEN INC
Biotechnology
2022
Amendment No. 3 to Master Supply Agreement by and among FibroGen, Inc., Shanghai SynTheAll Pharmaceutical Co., Ltd., and STA Pharmaceutical Hong Kong Limited, dated as of January...
Supply Agreements
FIBROGEN INC
Biotechnology
2021
Astellas EU Supply Agreement by and between FibroGen, Inc. and Astellas Pharma Europe Ltd, effective as of January 1, 2021
Supply Agreements
FIBROGEN INC
Biotechnology
2021
Master Services Agreement by and between FibroGen, Inc. and Samsung Biologics Co., Ltd., effective as of October 30, 2020
Services Agreements
FIBROGEN INC
Biotechnology
IL
2021
Collaboration Agreement by and between FibroGen, Inc. and Astellas Pharma Inc., effective June 1, 2005
Collaboration Agreements
FIBROGEN INC
Biotechnology
CA
2020
Amendment No. 1 to Master Supply Agreement by and among FibroGen, Inc., Shanghai SynTheAll Pharmaceutical Co., Ltd. and STA Pharmaceutical Hong Kong Limited, effective as of May...
Supply Agreements
FIBROGEN INC
Biotechnology
2020
Commercial Supply Agreement by and between FibroGen, Inc. and Catalent Pharma Solutions, LLC, effective as of January 1, 2020
Supply Agreements
FIBROGEN INC
Biotechnology
2020
Amendment No. 33 to the Process Development and Clinical Supply Agreement, by and between FibroGen, Inc. and Boehringer Ingelheim Biopharmaceuticals GmbH, effective as of January...
Development Agreements
FIBROGEN INC
Biotechnology
2019
Amendment No. 1 to Collaboration Agreement, by and between FibroGen, Inc. and Astellas Pharma Inc., effective as of January 1, 2013
Collaboration Agreements
FIBROGEN INC
Biotechnology
2019
Work Order No. 1 to the Process Development and Clinical Supply Agreement, by and between FibroGen, Inc. and Boehringer Ingelheim Biopharmaceuticals GmbH, effective as of...
Development Agreements
FIBROGEN INC
Biotechnology
2018
Amendment No. 32 to the Process Development and Clinical Supply Agreement, by and between FibroGen, Inc. and Boehringer Ingelheim Biopharmaceuticals GmbH, effective as of...
Development Agreements
FIBROGEN INC
Biotechnology
2018
Collaboration Agreement, by and between FibroGen, Inc. and Astellas Pharma Inc., effective as of June 1, 2005
Collaboration Agreements
FIBROGEN INC
Biotechnology
CA
2017
State-Owned Construction Land Use Right Granting Contract Promulgated by Ministry of Land and Resources of the Peoples Republic of China State Administration for Industry and...
Administration Agreements
FIBROGEN INC
Biotechnology
2017
Amendment No. 31 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
Biotechnology
2017
Amendment No. 30 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
Biotechnology
2017
Amendment No. 29 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
Biotechnology
2017
Amendment No. 26 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 25 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 24 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 22 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
Biotechnology
2016
AMENDMENT NO. 23 TO THE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
Biotechnology
2015
AMENDMENT NO. 21 TO THE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
Biotechnology
2015
AMENDMENT NO. 20 TO THE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
Biotechnology
2015
AMENDMENT NO.19 TO THE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
Biotechnology
2015
AMENDMENT NO.17 TOTHE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
Biotechnology
2015
AMENDMENT NO. 16 TO THE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
Biotechnology
2015
AMENDMENT NO. 15 TO THE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
Biotechnology
2015